Transplantation of kidneys harvested from non-heart-beating donors: early and long-term results. 1996

M J Pacholczyk, and B Lagiewska, and M Szostek, and A Chmura, and M Morzycka-Michalik, and D Rowińska-Stryjecka, and J Wałaszewski, and W Rowiński
Department of General and Transplantation Surgery, Warsaw Medical School, Poland.

The purpose of this retrospective study was to evaluate results of non-heart-beating donor (NHBD) kidney transplantation. Between Jan 1986 and Dec 1994, 80 out of 582 cadaveric kidneys were harvested from NHBD (31.9 min +/- 24 after cardiac arrest). The results in the NHBD group (76 recipients) were compared with those obtained after transplantation of kidneys harvested from heart-beating donors (HBD) with respect to early graft function, and the graft and recipient's survival. Both groups were matched for sex, age, PRA level, number of HLA mismatches, and cold ischemia time. Triple immunosuppression therapy was used in both groups. Acute tubular necrosis (ATN) was observed significantly more frequently in the NHBD group (50 of 76 recipients vs 33 of 100 in the HBD group). The striking finding of this study was that the occurrence of primary non-function was the same in both groups and that the main cause of it was acute rejection. The 1-year patient and graft survival rates were 98.7% and 81.6% for the NHBD group and 99% and 90% for the HBD group, respectively. There was also no statistical difference in the serum creatinine concentration in both groups. We concluded that despite an increased incidence of ATN in the NHBD kidney recipients, the long-term results are good and comparable with those in the HBD group.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D014019 Tissue Donors Individuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients. Organ Donors,Donors,Ovum Donors,Semen Donors,Transplant Donors,Donor,Donor, Organ,Donor, Ovum,Donor, Semen,Donor, Tissue,Donor, Transplant,Donors, Organ,Donors, Ovum,Donors, Semen,Donors, Tissue,Donors, Transplant,Organ Donor,Ovum Donor,Semen Donor,Tissue Donor,Transplant Donor
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

M J Pacholczyk, and B Lagiewska, and M Szostek, and A Chmura, and M Morzycka-Michalik, and D Rowińska-Stryjecka, and J Wałaszewski, and W Rowiński
January 1997, Transplantation proceedings,
M J Pacholczyk, and B Lagiewska, and M Szostek, and A Chmura, and M Morzycka-Michalik, and D Rowińska-Stryjecka, and J Wałaszewski, and W Rowiński
January 2001, Transplantation proceedings,
M J Pacholczyk, and B Lagiewska, and M Szostek, and A Chmura, and M Morzycka-Michalik, and D Rowińska-Stryjecka, and J Wałaszewski, and W Rowiński
November 2002, Transplantation proceedings,
M J Pacholczyk, and B Lagiewska, and M Szostek, and A Chmura, and M Morzycka-Michalik, and D Rowińska-Stryjecka, and J Wałaszewski, and W Rowiński
January 2001, Transplantation proceedings,
M J Pacholczyk, and B Lagiewska, and M Szostek, and A Chmura, and M Morzycka-Michalik, and D Rowińska-Stryjecka, and J Wałaszewski, and W Rowiński
January 1999, Transplantation proceedings,
M J Pacholczyk, and B Lagiewska, and M Szostek, and A Chmura, and M Morzycka-Michalik, and D Rowińska-Stryjecka, and J Wałaszewski, and W Rowiński
October 1995, Transplantation proceedings,
M J Pacholczyk, and B Lagiewska, and M Szostek, and A Chmura, and M Morzycka-Michalik, and D Rowińska-Stryjecka, and J Wałaszewski, and W Rowiński
January 2003, The Journal of urology,
M J Pacholczyk, and B Lagiewska, and M Szostek, and A Chmura, and M Morzycka-Michalik, and D Rowińska-Stryjecka, and J Wałaszewski, and W Rowiński
February 1996, Transplantation proceedings,
M J Pacholczyk, and B Lagiewska, and M Szostek, and A Chmura, and M Morzycka-Michalik, and D Rowińska-Stryjecka, and J Wałaszewski, and W Rowiński
October 1991, Transplantation proceedings,
M J Pacholczyk, and B Lagiewska, and M Szostek, and A Chmura, and M Morzycka-Michalik, and D Rowińska-Stryjecka, and J Wałaszewski, and W Rowiński
September 2003, The Journal of urology,
Copied contents to your clipboard!